J-TARGET,Japanese Telmisartan Study for Antihypertensive Good Effect in Long Term Observation

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The primary objective of this post marketing survey is to prospectively investigate patients with hypertension treated with Micardis Tablets (hereinafter "this drug") in routine clinical settings for 3 years in order to determine the following:

1. Adverse events and adverse drug reactions under long-term use

2. Blood pressure measurements during the survey period

3. Determination of the incidence of cerebrovascular and cardiovascular events under use of this drug in routine clinical settings

4. Patient's lifestyle and background factors that are considered to affect the occurrence of cerebrovascular and cardiovascular events

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Telmisartan

Criteria

Inclusion criteria:

Hypertension patients unadministered Micardis.

Exclusion criteria:

1. Patients with a history of hypersensitivity to any ingredient of this product.

2. Pregnant woman or possibly pregnant woman

3. Patients with extremely poor bile secretion or patients with serious hepatic disorder